Associate Director, Strategic Engagements, Community Networks
Ferring Pharmaceuticals
Summary
Ferring Pharmaceuticals is on a mission to transform the treatment of bladder cancer with ADSTILADRIN® (nadofaragene firadenovec-vncg), the first and only FDA-approved intravesical gene therapy for the treatment of adult patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). We are seeking innovative, entrepreneurial thinkers to join our U.S. Uro-Oncology commercial team.
Job description
This is a highly visible, strategic role for a commercially minded leader with urology experience, strong executive presence, and a track record of driving impact through influential customer engagement. The Associate Director, Strategic Engagements, Community Networks is responsible for developing and executing strategic external engagement initiatives across community-based urology practices, large independent urology groups, and other high-impact stakeholders supporting the ADSTILADRIN® brand.
Responsibilities
- Lead and support strategic engagement activities across the bladder cancer healthcare ecosystem, including community-based urology practices, large independent urology groups (including LUGPA affiliates), and other priority accounts.
- Develop and execute engagement strategies that strengthen relationships with influential physicians, advanced practice providers, administrators, nurses, and operational leaders.
- Identify, prioritize, and monitor key opinion leaders, academic centers, and strategic accounts; ensure coordinated deployment of appropriate commercial resources.
- Identify emerging trends, operational barriers, treatment pathway opportunities, and evolving customer needs, translating insights into actionable recommendations that inform brand strategy, lifecycle planning, evidence needs, and future growth opportunities.
- Communicate complex scientific and clinical concepts with clarity and credibility to support strategic customer engagement and commercial objectives.
- Partner with Marketing, Medical Affairs, Market Access, Sales Leadership, Commercial Operations, and Field Medical to develop coordinated engagement strategies and ensure aligned execution across customer touchpoints.
- Support planning and execution of advisory boards, roundtables, executive engagements, and peer-to-peer educational initiatives.
- Collaborate on engagement planning and execution at major congresses and priority scientific meetings by identifying high-priority stakeholders, supporting engagement planning, and synthesizing post-congress insights.
- Build trusted relationships with key opinion leaders, operational decision-makers, and emerging influencers across assigned strategic accounts.
- Monitor competitive activity, treatment trends, practice evolution, and healthcare delivery changes impacting NMIBC management.
- Maintain a deep understanding of practice operations, referral patterns, reimbursement considerations, and treatment workflows.
- Partner with the Strategic Engagements team to ensure consistent insight generation, dissemination, and cross-functional communication.
- Support development of strategic account plans that align customer engagement activities with broader commercial priorities.
Requirements
- Bachelor's degree required; advanced degree (PhD, PharmD, MD, or MBA) preferred.
- Minimum of 5–8 years of progressive pharmaceutical industry experience; combination of sales, medical affairs, and/or marketing experience preferred.
- Demonstrated success developing strategic relationships within the oncology healthcare ecosystem, including urologists, uro-oncologists, and other healthcare stakeholders influencing patient care; oncology or urology experience required.
- Strong background in commercial strategy, brand planning, professional education, and society engagement preferred.
- Successful product launch experience strongly preferred; experience with first-in-class therapies a plus.
- Proven ability to generate and leverage customer insights to shape market development and brand strategy.
- Strong analytical, strategic thinking, and problem-solving skills.
- Exceptional communication skills, including written, verbal, and presentation capabilities.
- Familiarity with promotional review processes and compliant external engagement required.
- Ability to travel frequently (approximately 50–65%).
Requirements
- Bachelor's degree required
- Advanced degree (PhD, PharmD, MD, or MBA) preferred
- Minimum of 5–8 years of progressive pharmaceutical industry experience
- Combination of sales, medical affairs, and/or marketing experience preferred
- Demonstrated success developing strategic relationships within the oncology healthcare ecosystem
- Oncology or urology experience required
- Strong background in commercial strategy, brand planning, professional education, and society engagement preferred
- Successful product launch experience strongly preferred
- Experience with first-in-class therapies a plus
- Proven ability to generate and leverage customer insights to shape market development and brand strategy
- Strong analytical, strategic thinking, and problem-solving skills
- Exceptional communication skills, including written, verbal, and presentation capabilities
- Familiarity with promotional review processes and compliant external engagement required
- Ability to travel frequently (approximately 50–65%)
Benefits
- Comprehensive healthcare
- 401(k) plan
- Company match
- Short-term disability coverage
- Long-term disability coverage
- Basic life insurance
- Wellness benefits
- Tuition reimbursement
- Paid parental leave
- Paid holidays
- Vacation time
- Sick time
- Annual bonus
Company overview
Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specializing in reproductive health, maternal health, gastroenterology, and urology. Founded in 1950 by Dr. Frederik Paulsen Sr. and Dr. Eva Paulsen in Malmö, Sweden, the company has grown into a global leader with headquarters in Saint-Prex, Switzerland. Ferring employs over 7,000 people worldwide and operates in more than 50 countries, marketing its products in over 100 countries. The company is privately owned and research-driven, with a strong commitment to building families and helping people live better lives. Ferring has been developing treatments for mothers and babies for over 50 years and is at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. The company's portfolio includes leading products such as Menopur for reproductive medicine, Pentasa for gastroenterology, and Adstiladrin for bladder cancer treatment. With manufacturing facilities across Europe, South America, China, India, and the United States, Ferring maintains a robust global presence while maintaining its focus on specialty biopharmaceuticals that address significant unmet medical needs.